Calcium and Phosphate Levels are Among Other Factors Associated with Metabolic Syndrome in Patients with Normal Weight

References

• O’Neill S, O’Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16:1–12. doi:10.1111/obr.12229
   PubMed Web of Science ®Google Scholar
• Buscemi S, Chiarello P, Buscemi C, et al. Characterization of metabolically healthy obese people and metabolically unhealthy normal-weight people in a general population cohort of the ABCD study. J. Diabetes Res. 2017;2017:1–9. doi:10.1155/2017/9294038
   Web of Science ®Google Scholar
• Stefan N, Schick F, HU H. Causes, characteristics, and consequences of metabolically unhealthy normal weight in humans. Cell Metab. 2017;26:292–300. doi:10.1016/j.cmet.2017.07.008
   PubMed Web of Science ®Google Scholar
• Mozos I, Marginean O. Links between Vitamin D deficiency and cardiovascular diseases. Biomed Res Int. 2015;1–12.
   Google Scholar
• Saltevo J, Niskanen L, Kautiainen H, et al. Serum calcium level is associated with metabolic syndrome in the general population: FIN-D2D study. Eur J Endocrinol. 2011;165:429–434. doi:10.1530/EJE-11-0066
   PubMedGoogle Scholar
• Baek JH, Jin S-M, Bae JC, et al. Serum calcium and the risk of incident metabolic syndrome: a 4.3-year retrospective longitudinal study. Diabetes Metab J. 2017;41:60–68. doi:10.4093/dmj.2017.41.1.60
   PubMedGoogle Scholar
• Osadnik T, Osadnik K, Pawlas N, et al. Metabolic and genetic profiling of young adults with and without a family history of premature coronary heart disease (MAGNETIC). Study design and methodology. Arch Med Sci. 2019;15.
   Google Scholar
• Phillips P, Pain R. Correcting the calcium. Br Med J. 1977;1(6061):598.
   Google Scholar
• R. Development Core Team. R: A Language and Environment for Statistical Computing [Homepage on the Internet]. Vienna: R Foundation for Statistical Computing; 2016. Available from: http://www.R-project.org/. Accessed April 2, 2020.
   Google Scholar
• PASS 15 Power Analysis and Sample Size Software [homepage on the Internet]. Utah: NCSS; 2017. Available from: https://www.ncss.com/software/pass/. Accessed April 2, 2020.
   Google Scholar
• Ahlström T, Hagström E, Larsson A, Rudberg C, Lind L, Hellman P. Correlation between plasma calcium, parathyroid hormone (PTH) and the metabolic syndrome (MetS) in a community-based cohort of men and women. Clin Endocrinol. 2009;71(5):673–678. doi:10.1111/j.1365-2265.2009.03558.x
   PubMedGoogle Scholar
• Suliga E, Kozieł D, Głuszek S. Prevalence of metabolic syndrome in normal weight individuals. Ann Agric Environ Med. 2016;23(4):631–635. doi:10.5604/12321966.1226858
   PubMed Web of Science ®Google Scholar
• Wong SK, Chin KY, Suhaimi FH, Ahmad F, Ima-Nirwana S. The relationship between metabolic syndrome and osteoporosis: a review. Nutrients. 2016;8(6):347. doi:10.3390/nu8060347
   PubMed Web of Science ®Google Scholar
• Yamaguchi T, Kanazawa I, Takaoka S, Sugimoto T. Serum calcium is positively correlated with fasting plasma glucose and insulin resistance, independent of parathyroid hormone, in male patients with type 2 diabetes mellitus. Metabolism. 2011;60(9):1334–1339. doi:10.1016/j.metabol.2011.02.003
   PubMedGoogle Scholar
• Sun G, Vasdev S, Martin GR, Gadag V, Zhang H. Altered calcium homeostasis is correlated with abnormalities of fasting serum glucose, insulin resistance, and beta-cell function in the Newfoundland population. Diabetes. 2005;54(11):3336–3339. doi:10.2337/diabetes.54.11.3336
   PubMed Web of Science ®Google Scholar
• Lind L, Jakobsson S, Lithell H, Wengle B, Ljunghall S. Relation of serum calcium concentration to metabolic risk factors for cardiovascular disease. BMJ. 1988;297(6654):960–963. doi:10.1136/bmj.297.6654.960
   PubMedGoogle Scholar
• Peredes S, Matta-Coelho C, Monteiro M, et al. Copper levels, calcium levels and metabolic syndrome. Revista Portuguesa de Diabetes. 2016;11(3):99–105.
   Google Scholar
• Kim MK, Kim G, Jang EH, et al. Altered calcium homeostasis is correlated with the presence of metabolic syndrome and diabetes in middle-aged and elderly Korean subjects: the Chungju Metabolic Disease Cohort study (CMC study). Atherosclerosis. 2010;212(2):674–681. doi:10.1016/j.atherosclerosis.2010.07.005
   PubMedGoogle Scholar
• Jorde R, Sundsfjord J, Fitzgerald P, Bønaa KH. Serum calcium and cardiovascular risk factors and diseases: the Tromsø study. Hypertension. 1999;34(3):484–490. doi:10.1161/01.HYP.34.3.484
   PubMed Web of Science ®Google Scholar
• Aoki K, Miyagawa. Correlation of increased serum calcium with elevated blood pressure and vascular resistance during calcium infusion in normotensive man. J Hypertens. 1990;8:579–583. doi:10.1097/00004872-199006000-00012
   PubMed Web of Science ®Google Scholar
• Jehle S, Lardi A, Felix B, Hulter HN, Stettler C, Krapf R. Effect of large doses of parenteral vitamin D on glycaemic control and calcium/phosphate metabolism in patients with stable type 2 diabetes mellitus: a randomised, placebo-controlled, prospective pilot study. Swiss Med Wkly. 2014;144:13942.
   Google Scholar
• Baz-Hecht M, Goldfine AB. The impact of vitamin D deficiency on diabetes and cardiovascular risk. Curr Opin Endocrinol Diab Obes. 2010;17(2):113–119. doi:10.1097/MED.0b013e3283372859
   PubMedGoogle Scholar
• Bener A, Al-Hamaq AO, Kurtulus EM, Abdullatef WK, Zirie M. The role of vitamin D, obesity and physical exercise in regulation of glycemia in Type 2 Diabetes Mellitus patients. Diabetes Metab Syndr. 2016;10(4):198–204. doi:10.1016/j.dsx.2016.06.007
   PubMed Web of Science ®Google Scholar
• Munoz-Garach A, Garcia-Fontana B, Munoz-Torres M. Vitamin D status, calcium intake and risk of developing type 2 diabetes: an unresolved issue. Nutrients. 2019;11(3):E642. doi:10.3390/nu11030642
   PubMed Web of Science ®Google Scholar
• Almaden Y, Hernandez A, Torregrosa V, et al. High phosphate level directly stimulates parathyroid hormone secretion and synthesis by human parathyroid tissue in vitro. J Am Soc Nephrol. 1998;9(10):1845–1852.
   PubMedGoogle Scholar
• Chiu KC, Chuang LM, Lee NP, et al. Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level. Metabolism. 2000;49(11):1501–1505. doi:10.1053/meta.2000.17708
   PubMedGoogle Scholar
• Park W, Kim BS, Lee JE, et al. Serum phosphate levels and the risk of cardiovascular disease and metabolic syndrome: a double-edged sword. Diabetes Res Clin Pract. 2009;83(1):119–125. doi:10.1016/j.diabres.2008.08.018
   PubMed Web of Science ®Google Scholar
• Paula FJ, Plens AE, Foss MC. Effects of hypophosphatemia on glucose tolerance and insulin secretion, Horm.. Metab Res. 1998;30:281–284. doi:10.1055/s-2007-978884
   PubMedGoogle Scholar
• Haglin L. Hypophosphatemia causa of the disturbed metabolism in the metabolic syndrome. Med Hypotheses. 2001;56:657–663. doi:10.1054/mehy.2000.1272
   PubMedGoogle Scholar
• Dhingra R, Sullivan LM, Fox CS, et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med. 2007;167(9):879–885. doi:10.1001/archinte.167.9.879
   PubMed Web of Science ®Google Scholar
• Kalaitzidis R, Tsimihodimos V, Bairaktari E, Siamopoulos KC, Elisaf M. Disturbances of phosphate metabolism: another feature of metabolic syndrome. Am J Kidney Dis. 2005;45(5):851–858. doi:10.1053/j.ajkd.2005.01.005
   PubMedGoogle Scholar
• Franzini M, Scataglini I, Ricchiuti A, et al. Association between plasma gamma-glutamyltransferase fractions and metabolic syndrome among hypertensive patients. Sci Rep. 2017;7(1):12003. doi:10.1038/s41598-017-12356-w
   PubMedGoogle Scholar
• Kunutsor SK, Apekey TA, Seddoh D. Gamma glutamyltransferase and metabolic syndrome risk: a systematic review and dose–response meta-analysis. Int J Clin Pract. 2015;69(1):136–144. doi:10.1111/ijcp.12507
   PubMed Web of Science ®Google Scholar
• Krishnamurthy VR, Baird BC, Wei G, Greene T, Raphael K, Beddhu S. Associations of serum alkaline phosphatase with metabolic syndrome and mortality. Am J Med. 2011;124(6):566.e1–7. doi:10.1016/j.amjmed.2010.11.030
   PubMedGoogle Scholar
• Fadini GP, Pauletto P, Avogaro A, Rattazzi M. The good and the bad in the link between insulin resistance and vascular calcification. Atherosclerosis. 2007;193(2):241–244. doi:10.1016/j.atherosclerosis.2007.05.015
   PubMedGoogle Scholar
• Sigrist MK, Taal MW, Bungay P, McIntyre CW. Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol. 2007;2(6):1241–1248. doi:10.2215/CJN.02190507
   PubMedGoogle Scholar
• Cheung CL, Tan KC, Lam KS, Cheung BM. The relationship between glucose metabolism, metabolic syndrome, and bone-specific alkaline phosphatase: a structural equation modeling approach. J Clin Endocrinol Metab. 2013;98:3856–3863. doi:10.1210/jc.2013-2024
   PubMed Web of Science ®Google Scholar